Literature DB >> 24090509

Expression of cell cycle and apoptosis-related proteins in ameloblastoma and keratocystic odontogenic tumor.

Rashmi Metgud1, Kanupriya Gupta.   

Abstract

Tumors arising from epithelium of the odontogenic apparatus or from its derivatives or remnants exhibit considerable histologic variation and are classified into several benign and malignant entities. A high proliferative activity of the odontogenic epithelium in ameloblastoma (AM) and keratocystic odontogenic tumor (KCOT) has been demonstrated in some studies individually. However, very few previous studies have simultaneously evaluated cell proliferation and apoptotic indexes in AM and KCOT, comparing both lesions. The aim of this study was to assess and compare cell proliferation and apoptotic rates between these two tumors. Specimens of 15 solid AM and 15 KCOT were evaluated. The proliferation index (PI) was assessed by immunohistochemical detection of Ki-67 and the apoptotic index (AI) by methyl green-pyronin stain. KCOT presented a higher PI than AM (P < .05). No statistically significant difference was found in the AI between AM and KCOT. PI and AI were higher in the peripheral cells of AM and respectively in the suprabasal and superficial layers of KCOT. In conclusion, KCOT showed a higher cell proliferation than AM and the AI was similar between these tumors. These findings reinforce the classification of KCOT as an odontogenic tumor and should contribute to its aggressive clinical behavior.
© 2013.

Entities:  

Keywords:  Ameloblastoma; Apoptosis; KCOT; Ki-67; Proliferation

Mesh:

Substances:

Year:  2013        PMID: 24090509     DOI: 10.1016/j.anndiagpath.2013.06.006

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  7 in total

1.  Clinicopathological and cell proliferation evaluation of ameloblastomas and keratocystic odontogenic tumors: a 10 year retrospective study.

Authors:  Leorik Pereira da Silva; Marianna Sampaio Serpa; Thalita Santana; George João Ferreira do Nascimento; Emanuel Sávio de Souza Andrade; Ana Paula Veras Sobral
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-17       Impact factor: 2.503

2.  Role of HIF-1α and CASPASE-3 in cystogenesis of odontogenic cysts and tumors.

Authors:  Natacha M M da Costa; Adriane S de Siqueira; André L R Ribeiro; Maria S da Silva Kataoka; Ruy G Jaeger; Sérgio M de Alves-Júnior; Andrew M Smith; João de Jesus Viana Pinheiro
Journal:  Clin Oral Investig       Date:  2017-02-25       Impact factor: 3.573

3.  Comparison between Manual and Automated Methods for Ki-67 Immunoexpression Quantification in Ameloblastomas.

Authors:  Rogelio González-González; Nelly Molina-Frechero; Ramón G Carreón-Burciaga; Sandra López-Verdín; Carlos Robles-Bonilla; Vanesa Pereira-Prado; Ronell Bologna-Molina
Journal:  Anal Cell Pathol (Amst)       Date:  2016-10-24       Impact factor: 2.916

4.  Bioinformatics Analysis Reveals Genes Involved in the Pathogenesis of Ameloblastoma and Keratocystic Odontogenic Tumor.

Authors:  Eliane Macedo Sobrinho Santos; Hércules Otacílio Santos; Ivoneth Dos Santos Dias; Sérgio Henrique Santos; Alfredo Maurício Batista de Paula; John David Feltenberger; André Luiz Sena Guimarães; Lucyana Conceição Farias
Journal:  Int J Mol Cell Med       Date:  2016-12-06

5.  Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns.

Authors:  Ramón Gil Carreón-Burciaga; Rogelio González-González; Nelly Molina-Frechero; Ronell Bologna-Molina
Journal:  Dis Markers       Date:  2015-12-28       Impact factor: 3.434

6.  Maspin, Syndecan-1, and Ki-67 in the Odontogenic Keratocyst: An Immunohistochemical Analysis.

Authors:  Huda M Hammad; Omar M Nagrash; Rima A Safadi
Journal:  Int J Dent       Date:  2020-07-14

7.  A Novel lncRNA ENST00000512916 Facilitates Cell Proliferation, Migration and Cell Cycle Progression in Ameloblastoma.

Authors:  Yan Sun; Xing Niu; Guannan Wang; Xue Qiao; Lijie Chen; Ming Zhong
Journal:  Onco Targets Ther       Date:  2020-02-19       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.